Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Loser

Alexion Pharmaceuticals Inc (ALXN) pushed the Drugs industry lower today making it today's featured Drugs loser. The industry as a whole closed the day down 0.2%. By the end of trading, Alexion Pharmaceuticals Inc fell 50 cents (-0.8%) to $63.57 on light volume. Throughout the day, 918,868 shares of Alexion Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.5 million shares. The stock ranged in price between $62.72-$65.05 after having opened the day at $64.69 as compared to the previous trading day's close of $64.07. Other company's within the Drugs industry that declined today were: China Sky One Medical Inc (CSKI), down 15.7%, Medgenics Inc (MDGN), down 15.7%, Vermillion Inc (VRML), down 15.2%, and Tianyin Pharmaceutical Co Inc (TPI), down 13.6%.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. Alexion Pharmaceuticals Inc has a market cap of $12 billion and is part of the health care sector. The company has a P/E ratio of 81, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 59.1% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Alexion as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, expanding profit margins and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

• You can view the full Alexion Ratings Report.

On the positive front, Arrowhead Research Corporation (ARWR), up 40.2%, Cardium Therapeutics Inc (CXM), up 12.8%, Reliv' International Inc (RELV), up 8.5%, and Depomed Inc (DEPO), up 7.3%, were all gainers within the drugs industry with Johnson & Johnson (JNJ) being today's featured drugs industry winner.

• Use our drugs section to find industry-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF (XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech (BIS).

• Find other investment ideas from our top rated ETFs lists.

For more information on Alexion Pharmaceuticals Inc. click any of the following:

• Alexion Pharmaceuticals Inc. Stock Price

• Alexion Pharmaceuticals Inc. Analyst Ratings

• Alexion Pharmaceuticals Inc. Key Stats & Profile

• Alexion Pharmaceuticals Inc. Earnings

• Alexion Pharmaceuticals Inc. Ratio Comparison

• Alexion Pharmaceuticals Inc. Growth Rates

• Alexion Pharmaceuticals Inc. Balance Sheet

• Alexion Pharmaceuticals Inc. Cash Flow

• Alexion Pharmaceuticals Inc. Income Statement